Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brunangelo Falini

Showing results (21-30 of 246) with videos related to

Pageof 25
Sort By:
American Journal of Hematology|October 22, 2025
CD30 as a Target Molecule in the Diagnosis and Therapy of LymphomasHarald Stein, Brunangelo Falini
Haematologica|November 3, 2009
Mantle cell lymphomaStefano A Pileri, Brunangelo Falini
American Journal of Hematology|January 6, 2023
Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemiaBrunangelo Falini, Maria Paola Martelli
Blood|January 10, 2002
Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistryBrunangelo Falini, David Y Mason
Blood|September 17, 2011
NPM1-mutated AML: targeting by disassemblingBrunangelo Falini, Maria Paola Martelli
Haematologica|July 3, 2009
Anaplastic large cell lymphoma: changes in the World Health Organization classification and perspectives for targeted therapyBrunangelo Falini, Maria Paola Martelli
Best Practice & Research. Clinical Haematology|November 23, 2015
Impact of genomics in the clinical management of patients with cytogenetically normal acute myeloid leukemiaBrunangelo Falini, Maria Paola Martelli
Blood|May 4, 2021
BCOR gene alterations in hematologic diseasesPaolo Sportoletti, Daniele Sorcini, Brunangelo Falini
British Journal of Haematology|June 30, 2023
A comparison of the International Consensus and 5th WHO classifications of T-cell lymphomas and histiocytic/dendritic cell tumoursBrunangelo Falini, Stefano Lazzi, Stefano Pileri
F1000Research|May 18, 2018
Recent advances in understanding and managing hairy cell leukemiaTobias Roider, Brunangelo Falini, Sascha Dietrich
Pageof 25

Showing results (21-30 of 246) with videos related to

Sort By:
Pageof 25
American Journal of Hematology|October 22, 2025
CD30 as a Target Molecule in the Diagnosis and Therapy of LymphomasHarald Stein, Brunangelo Falini
Haematologica|November 3, 2009
Mantle cell lymphomaStefano A Pileri, Brunangelo Falini
American Journal of Hematology|January 6, 2023
Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemiaBrunangelo Falini, Maria Paola Martelli
Blood|January 10, 2002
Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistryBrunangelo Falini, David Y Mason
Blood|September 17, 2011
NPM1-mutated AML: targeting by disassemblingBrunangelo Falini, Maria Paola Martelli
Haematologica|July 3, 2009
Anaplastic large cell lymphoma: changes in the World Health Organization classification and perspectives for targeted therapyBrunangelo Falini, Maria Paola Martelli
Best Practice & Research. Clinical Haematology|November 23, 2015
Impact of genomics in the clinical management of patients with cytogenetically normal acute myeloid leukemiaBrunangelo Falini, Maria Paola Martelli
Blood|May 4, 2021
BCOR gene alterations in hematologic diseasesPaolo Sportoletti, Daniele Sorcini, Brunangelo Falini
British Journal of Haematology|June 30, 2023
A comparison of the International Consensus and 5th WHO classifications of T-cell lymphomas and histiocytic/dendritic cell tumoursBrunangelo Falini, Stefano Lazzi, Stefano Pileri
F1000Research|May 18, 2018
Recent advances in understanding and managing hairy cell leukemiaTobias Roider, Brunangelo Falini, Sascha Dietrich
Pageof 25